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CarcinomaAbstract Squamous cell carcinoma (SCC) of the nasopharynx is amongst the most common head
and neck cancers. The most common distant metastases are to the bone, liver and lung. Herein, we
are reporting a rare case of a 61-year-old man with nasopharyngeal carcinoma (NPC) who
presented with 3 weeks history of blood streaked sputum, post nasal drip and blocked nose with
no history of epistaxis, tinnitus and unilateral hearing loss. Almost 2 years upon completion of
his concurrent chemotherapy and radiotherapy, he developed a right hypochondrium mass and
underwent colonoscopy which revealed a mass in ascending colon and which was then subsequently
resected via right hemicolectomy. Histological analyses from the resected specimen conﬁrmed its
nasopharyngeal origin.
ª 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Nasopharyngeal carcinoma (NPC) is a tumour arising from
the epithelial cells of nasopharynx. It is the commonest epithe-
lial cancer in adult.1 It is a unique tumour which is endemic to
Southern China speciﬁcally amongst Cantonese origin and
Southeast Asia affecting 10–50 per 100,000 populations per
year.2 Intermediate incidences are seen in the Mediterranean
Basin and the Artic.3 In Malaysia, NPC is a prevalent cancer.Based on the National Cancer Registry 2003, there were 1125
incident cases of NPC in Peninsular Malaysia. Amongst the
diagnosed patients, 57% were Chinese, 19% Malay, 1% were
Indians and the remaining 23% were from other ethnic
groups.4 The tumour can extend within or out of the nasophar-
ynx to the other lateral wall and or posterior superiorly to the
base of skull, or the palate, nasal cavity or oropharynx. It then
typically metastasizes to cervical lymph nodes.1 World Health
Organisation (WHO) classiﬁed NPC into 3 sub types: (1)
squamous cell carcinoma, typically found in older adult
population; (2) non keratinizing carcinoma; (3) undifferentiated
carcinoma.1 Commonly reported distant metastases of NPC
are to the bone 70–80%, viscera (liver 30%, lung 18%) and
at lower rate extra cervical lymph nodes (axillary, mediastinal,
pelvic, inguinal).5 For the past few years there are also reports
on distant metastasis in NPC to other rare sites of such as
pericardium,6 small bowel,7 sternum,8 rectum9 and intraed.
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colon are extremely rare and to our knowledge this is the ﬁrst
reported case of NPC with histologically conﬁrmed metastases
to colon.
2. Case report
A 61-year-old Chinese man presented with 3 weeks history of
blood streaked sputum, post nasal drip and blocked nose with
no history of epistaxis, tinnitus and unilateral hearing loss. He
has no cervical lymphadenopathy. Anterior rhinoscopy
showed hypertrophic inferior turbinates bilaterally with clear
mucous secretions and otoscopic examination showed no
abnormality. Endoscopic examination of the nasopharynx
revealed a nasopharyngeal mass covered with slough over
the left Fossa of Rosenmuller. The mass is obliterating the left
Eustachian tube opening. Histopathology ﬁnding of the biop-
sied mass reported as non-keratinizing NPC (WHO type III)
(see Fig. 1).
Computed tomography (CT) of the head and neck showed
soft tissue mass obliterating the left Fossa of Rosenmuller and
multiple small bilateral cervical lymph nodes less of subcentime-
ter dimension. Chest radiograph and Ultrasonography of
abdomen showed no signiﬁcant abnormalities. The patient
was diagnosed to have NPC stage T1N0M0 and was treated
with concurrent chemo radiation with weekly cisplatin. A com-
plete tumour response was achieved and he was in clinical
remission after completing his treatment until he presented
again with right hypochondriac mass 19 months later. Subse-
quent CT of the abdomen and pelvis revealed a heterogenous
lobulated mass in the region of caecum measuring 4.7 cm ·
6.2 cm · 5.8 cm with loss of plane with abdominal wall muscle
and surrounding mesentery fat streakiness. There is also a
heterogenous hypodense nodule in the right adrenal gland
measuring 3.6 cm · 3.0 cm · 4.9 cm with surrounding fat
streakiness which suggestive of right adrenal gland metastasis.
He was then referred to surgical team for further investiga-
tion. Colonoscopy was performed by the surgical team which
revealed a mass in the ascending colon. Biopsy taken fromFigure 1 The picture of biopsy taken from left Fossa of Rosenmuller
intercellular bridges.the mass in ascending colon reported as adenocarcinoma.
Two weeks later he underwent right hemicolectomy and review
of the histopathology ﬁnding from the right hemicolectomy
specimen conﬁrmed as metastatic NPC (see Fig. 2).
Microscopically the malignant cells are involving the serosa
and some malignant cells are seen within the lamina propria.
The tumour cells are negative for CK20 and CK7. Tumour
margins were completely resected. A month following the
surgery he developed right supraclavicular node and further
investigation with Multi-slice CT head, neck and thorax
revealed bilateral supraclavicular nodal metastasis and distant
metastasis to liver, lungs and right adrenal. Upon recovering
from surgery he was planned for 3 cycles of chemotherapy with
5-Flouracil and cisplatin. Unfortunately he developed episodes
of intestinal obstruction and was unﬁt for continuation of
treatment. His condition deteriorated and unfortunately he
succumbed to death 2 months later at home before being able
to undergo his treatment.
3. Discussion
Squamous cell carcinomas (SCC) of the head and neck are
relatively common and usually associated with radical surgery
and poor outcome.9 Prognosis is poor in those with advanced
or metastatic disease. NPC on the other hand offers good sur-
vival with non-surgical treatment. Aetiological factors include
Epstein–Barr virus (EBV), genetic susceptibility, and con-
sumption of food with possible carcinogen-volatile
nitrosamines.1 The incidence of metastases is often underesti-
mated with clinical diagnosis, as shown by three- to fourfold
increased rates of metastases of head and neck SCC, 26–
57% in autopsy studies compared to 5.3–23.7% in clinical
studies.9 There are multiple factors inﬂuencing the incidence
of distant metastases such as location of the primary tumour,
initial T and N stage of the neoplasm, and the presence or
absence of regional control above the clavicle. Incidence of
distant metastases is higher in patients with advanced nodal
disease, particularly in the presence of jugular vein invasion
or extensive soft tissue disease in the neck.11showed malignant cells exhibiting individual cell keratinization and
Figure 2 The picture of right hemicolectomy specimen showed malignant cells with squamous differentiation. The cells exhibit
individual cell keratinization and intercellular bridges.
Nasopharyngeal carcinoma with metastases to colon 203NPC is known for its propensity for both lymphatic and
haematogenous spread.6 It is clinically distinguishable from
cancers of the oral cavity and oropharynx by a high frequency
(up to 80–90%) of regional nodal metastasis at presentation,
with bilateral involvement in approximately half of the
patients.6 Hence, when comparing with lymph node metastasis,
distant metastasis is relatively uncommon. In reviewing 256
NPC patients, Ahmad and Stefani found a 36% overall inci-
dence of distant metastases in 51% in the autopsies. Bones
(48%), distant lymph nodes (43%), liver (36%), and lungs
(31%) were amongst the common sites of distant metastases,
whereas in autopsies liver was the most common site.6 Another
retrospective study done in Hong Kong reported that the com-
monest site of distant metastases was the skeleton and the medi-
an survival of all patients with distant metastases is 8 months.6
Intra-abdominal extra-hepatic involvement although rare, is
underrated. An autopsy series of 387 patients with metastatic
head and neck SCC found intra-abdominal involvement in
abdominal nodes (20%), kidney (16%), adrenals (15%), spleen
(9%), small bowel (4%), pancreas (4%) and stomach (3%).
Colorectal metastasis was only observed in three patients
(0.8%), demonstrating the rareness of this entity.9
Cancers involving the bowel are usually primary large or
small bowel cancers, direct invasion from primary cancers aris-
ing from other adjacent abdominal organs or peritoneal carci-
nomatosis. Metastatic cancer from malignancy outside the
abdomen involving the intestinal mucosa is relatively rare,
and can be associated with multiple surgical emergencies
including intestinal bleeding, perforation, or intussusception.7
Metastasis to the colorectal region from any extra
abdominal primary is uncommon. The most common extra-
abdominal primary tumours are malignant melanoma, breast
and lung tumours with estimated large bowel involvement in
27%, 5.3–12% and 2.2%, respectively.7 Colonic metastasis
from primary tumour in the nasopharynx is an extremely rare
event and has never been reported before. Hence to our best
knowledge this is the ﬁrst case of SCC of the nasopharynx,
metastasizing to the colon.Due the uniqueness and rarity of this case, it is important to
consider whether the colorectal lesion represents a metastatic
lesion or it is a new second primary tumour. However in this
case histological assessment of the resected specimen supports
the ﬁndings as the morphological features of the colorectal
tumour are similar to these of the primary nasopharyngeal ori-
gin. This refers to a metastatic, rather than a primary lesion. It
is estimated that up to 28.1% of patients with nasopharyngeal
SCC will develop distant metastases (5). One study suggested
48% of metastases were detected within 9 months of treatment
and 80% were detected within 2 years.6
Therefore it is important for clinicians to be more suspi-
cious and cautious when encountering patients to with gas-
trointestinal complaints, regardless of SCC remission status.
Presenting complaints in non-primary colorectal malignancies
are usually non-speciﬁc.7 Obstruction and perforation are poor
prognostic markers. Investigations such as CT thorax should
also be performed in addition to gastro-intestinal investiga-
tions to exclude the more common sites of metastases, as
screening patients with high risk features, such as bilateral
nodal disease, nodes of more than 6 cm or more than 3 nodes
involved and second primary tumours or recurrence, reveals
other distant metastatic lesions in more than 10% of patients.9
In addition to that, Akbas et al. reported that 18F-FDG PET/
CT examination recently showed higher sensitivity in detecting
distant metastases than conventional work up such as chest
radiograph, liver ultrasound and bone scan.8
Clinicians should be aware of high risk features of the pri-
mary tumour, the limitations of investigations and the concur-
rent presence of other distant metastases, which may
drastically change the treatment and outcome.
The survival rates in non-primary colorectal carcinoma vary
due to the rarity of the entity, different types of primary
tumours and tumour stages, at presentation. Lau et al. has
reported a good survival outcome of 22 months in a patient
with a complete small bowel obstruction caused by metastasis
from primary NPC.7 Another report from China mentioned a
good long term tumour control from radiotherapy.10 However,
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of a diffuse carcinomatosis and the outcome is poor. The
reported 5-year survival in SCC with distant metastases is only
6.4%.10 Factors associated with poor outcomes are obstruction
and perforation with median less than 10 months survival. At
present, although radiotherapy has a palliative role in bony
and occasionally lung and brain metastases, it appears to be
no role for adjuvant treatment (chemo or radiotherapy) in col-
orectal metastases and median survival is short, ranging from 3
to 5 months. Future strategies, targeting angiogenesis and cell
surface receptors, may be useful. In most cases, palliation is
preferred. Surgery should only be offered for palliation or
isolated colorectal segmental involvement.9
4. Conclusion
There are so far no reports on metastatic lesions of NPC to the
colon. Metastatic lesion to colorectal regions are most com-
monly seen in primary lesions of malignant melanoma, lobular
breast carcinoma and lung carcinoma. Even though head and
neck SCC can metastasize to this region, it occurs usually long
after commencement of initial treatment of the primary
tumour. In view of its rarity, metastasis to this unusual site
is not immediately suspected in patients with primary NPC
and was only known during histopathology analysis of the
resected colorectal specimen. Thus, emphasising the impor-
tance of maintaining a high index of suspicion in patients pre-
senting with non-speciﬁc gastro-intestinal complaints,
regardless of SCC disease status. Investigations should not
only determine the extent of colorectal metastases, but should
also exclude other common concurrent metastatic sites to raise
awareness amongst clinicians regarding the limitations of cur-
rent investigations in diagnosing metastases. Although there
are reports on a few selected patients with isolated segmental
disease may be beneﬁted from surgical intervention, still the
overall survival in non-primary colorectal carcinoma, especial-
ly SCC primary, is poor. Palliative treatment should always beconsidered in SCC colorectal lesions as the current adjuvant
treatment may not be beneﬁcial to these patients.
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